To Promote Tobacco Free Life in the Dental Practice in France
TOBAFREE-DP
1 other identifier
observational
139
1 country
1
Brief Summary
In France, 34% of the adult population is smoking every day. The links between smoking and the development of several chronic disorders is well established and smoking is directly implicated in most of the oral diseases such as cancers of the oral cavity. Thus, dentists have access to an area of the body that is actively affected and this gives them a central role in dispensing advice and support regarding smoking cessation. Dentists often cite issues such as lack of time or education as a reason for why they do not offer support for smoking cessation. A brief intervention can increase smoking cessation by 30 to 100% (ie 1-3% in absolute value). The "5A" approach integrates and extends the brief intervention. It consists in Asking about smoking status, Advising smokers of the benefit of stopping, Assessing motivation to quit, Assisting smokers in their quit attempt, Arranging follow-up with stop-smoking services. For practitioners who do not have enough time, a "3A" approach might be acceptable (Ask, Advice and Act) by providing details of local stop smoking services and/or prescribing nicotine replacement therapy (NRT). This very brief advice can be delivered in less than one minute. To investigators knowledge, the role of dentists in the French national tobacco-free program is not yet documented in France while since 2016, dentists can prescribe NRT with some products taken in charge by the French health insurance. An intervention taking part in the continuing professional development will be developed so the dentists fell legitimate, motivated and competent to talk with their patients about their tobacco consumption and to assist them in their smoking cessation process. This intervention based on the 5/3A approach and prescription of NRT will include a specific training and provision of management kit, with communication tools and network for appropriate references. Investigators hypothesize that 5/3A approach is feasible with adequate intervention in dental practices in France (dentists apply the approach to 90% of their patients) and that the format, the conditions, the barriers and the lever actions of its implementation are known.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2020
CompletedFirst Posted
Study publicly available on registry
August 5, 2020
CompletedStudy Start
First participant enrolled
April 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 13, 2021
CompletedNovember 10, 2021
November 1, 2021
5 months
July 31, 2020
November 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
5/3A approach
Acceptability for performing the 5/3A approach in the dental practice
1 month after inclusion (day0)
Study Arms (1)
Patient
Interventions
Patient will be interviewed : * tobacco consumption * reported question asked by the dentist about his/her tobacco consumption * presence and nature of reported advices given by the dentist * presence and nature of actions proposed by dentists for patients reporting tobacco consumption, including prescription of NRT * presence and nature of the actions carried out or envisaged by these patients, including - smoking cessation * contact with the general practioner * Fagerstrom score (2 questions) * demographic variables, age, sex, level of education * satisfaction
Eligibility Criteria
Patients of trained dentists to 3/5A strategy
You may qualify if:
- years or older
- smoker
- Will to participate to study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Bordeaux
Bordeaux, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2020
First Posted
August 5, 2020
Study Start
April 14, 2021
Primary Completion
September 13, 2021
Study Completion
September 13, 2021
Last Updated
November 10, 2021
Record last verified: 2021-11